Nazish Butt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nazish Butt has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
Amanullah Abbasi
Internal Medicine, Dow University of Health Sciences, Karachi, PAK
4 shared publicationsAli Akbar
1–6Department of Gastroenterology, Jinnah Postgraduate Medical Centre, Karachi, Sindh, Pakistan
3 shared publications- Amanullah Abbasi
Internal Medicine, Dow University of Health Sciences, Karachi, PAK
3 shared publications Farhan Haleem
Gastroenterology, Jinnah Postgraduate Medical Centre, Karachi, PAK
3 shared publicationsKhalid Mumtaz
Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States
3 shared publicationsSabir Ali
Department of Gastroenterology, Jinnah Postgraduate Medical Centre, Karachi 05444, Pakistan
3 shared publications
Latest Publications
- Open Access
- 17 October 2026
- Published by Springer Nature in BMC Infectious Diseases
Bulevirtide with or without Peg-IFNα-2a for chronic hepatitis D: a systematic review and meta-analysis of randomized controlled trials
Objective: To compare the efficacy and safety of bulevirtide (BLV) monotherapy versus BLV plus pegylated interferon alfa-2a (Peg-IFNα-2a) in adults with chronic hepatitis D. Methods: We conducted a systematic review and meta-analysis in accordance with PRISMA 2020 (PROSPERO: CRD420251137112). Randomized controlled trials (RCTs) directly comparing BLV plus Peg-IFNα-2a with BLV monotherapy were identified through PubMed/MEDLINE, Embase, Scopus, the Cochrane Library, Google Scholar, and ClinicalTrials.gov. The original searches were completed in August 2025. All information sources were searched again on September 21, 2026, to identify any newly published eligible trials. Trial-defined virological, biochemical, and combined responses and changes in HDV RNA and ALT were synthesized using random-effects models. The primary analyses used restricted maximum likelihood estimation with the Hartung–Knapp–Sidik–Jonkman (REML-HKSJ) adjustment. DerSimonian–Laird (DL) random-effects analyses with conventional normal-approximation confidence intervals were performed as sensitivity analyses. Results: Three RCTs comprising 225 patients were included. At week 24, virological response was numerically higher with BLV plus Peg-IFNα-2a, although the difference was not statistically significant (RR 2.07, 95% CI 0.38–11.40), while no difference was observed in combined response (RR 1.01, 95% CI 0.12–8.48). Combination therapy produced a greater reduction in HDV RNA (Hedges’ g − 0.96, 95% CI − 1.75 to − 0.18). In contrast, biochemical response favored BLV monotherapy (RR 0.36, 95% CI 0.17–0.78), as did ALT change (MD 45.58 U/L, 95% CI 33.51–57.65). At week 48, virological response favored combination therapy (RR 5.33, 95% CI 1.57–18.12), whereas biochemical and combined responses did not differ significantly between groups. At 24 weeks post-EOT, combined response favored combination therapy (RR 4.15, 95% CI 1.05–16.40), while the virological and biochemical response estimates remained imprecise. Peg-IFNα-2a containing combination regimens were associated with higher rates of neutropenia and thrombocytopenia. DL sensitivity analyses yielded narrower confidence intervals for several outcomes and changed the statistical significance of some longer-term estimates. Conclusions: BLV plus Peg-IFNα-2a was associated with greater virological suppression, whereas BLV monotherapy showed more favorable on-treatment biochemical responses. Follow-up estimates were based on only two randomized trials, with wide confidence intervals for several outcomes under the primary REML-HKSJ analysis. The available randomized evidence should therefore be interpreted cautiously, particularly for longer-term and post-treatment outcomes. Clinical trial number: Not applicable.
- 17 October 2026
- Published by Springer Nature in BMC Infectious Diseases
Open AccessBulevirtide with or without Peg-IFNα-2a for chronic hepatitis D: a systematic review and meta-analysis of randomized controlled trials
Objective: To compare the efficacy and safety of bulevirtide (BLV) monotherapy versus BLV plus pegylated interferon alfa-2a (Peg-IFNα-2a) in adults with chronic hepatitis D. Methods: We conducted a systematic review and meta-analysis in accordance with PRISMA 2020 (PROSPERO: CRD420251137112). Randomized controlled trials (RCTs) directly comparing BLV plus Peg-IFNα-2a with BLV monotherapy were identified through PubMed/MEDLINE, Embase, Scopus, the Cochrane Library, Google Scholar, and ClinicalTrials.gov. The original searches were completed in August 2025. All information sources were searched again on September 21, 2026, to identify any newly published eligible trials. Trial-defined virological, biochemical, and combined responses and changes in HDV RNA and ALT were synthesized using random-effects models. The primary analyses used restricted maximum likelihood estimation with the Hartung–Knapp–Sidik–Jonkman (REML-HKSJ) adjustment. DerSimonian–Laird (DL) random-effects analyses with conventional normal-approximation confidence intervals were performed as sensitivity analyses. Results: Three RCTs comprising 225 patients were included. At week 24, virological response was numerically higher with BLV plus Peg-IFNα-2a, although the difference was not statistically significant (RR 2.07, 95% CI 0.38–11.40), while no difference was observed in combined response (RR 1.01, 95% CI 0.12–8.48). Combination therapy produced a greater reduction in HDV RNA (Hedges’ g − 0.96, 95% CI − 1.75 to − 0.18). In contrast, biochemical response favored BLV monotherapy (RR 0.36, 95% CI 0.17–0.78), as did ALT change (MD 45.58 U/L, 95% CI 33.51–57.65). At week 48, virological response favored combination therapy (RR 5.33, 95% CI 1.57–18.12), whereas biochemical and combined responses did not differ significantly between groups. At 24 weeks post-EOT, combined response favored combination therapy (RR 4.15, 95% CI 1.05–16.40), while the virological and biochemical response estimates remained imprecise. Peg-IFNα-2a containing combination regimens were associated with higher rates of neutropenia and thrombocytopenia. DL sensitivity analyses yielded narrower confidence intervals for several outcomes and changed the statistical significance of some longer-term estimates. Conclusions: BLV plus Peg-IFNα-2a was associated with greater virological suppression, whereas BLV monotherapy showed more favorable on-treatment biochemical responses. Follow-up estimates were based on only two randomized trials, with wide confidence intervals for several outcomes under the primary REML-HKSJ analysis. The available randomized evidence should therefore be interpreted cautiously, particularly for longer-term and post-treatment outcomes. Clinical trial number: Not applicable.
- Open Access
- 19 September 2026
- Published by Springer Nature in Egyptian Liver Journal
- Vol. 16  (1) , 66
Hepatitis E vaccination in women of childbearing age: safety and tolerability outcomes
Background and objective: Hepatitis E virus is a major cause of acute viral hepatitis and is endemic in Pakistan, where it contributes substantially to morbidity and mortality among women of childbearing age. The Hecolin vaccine is a potentially useful preventive measure, but data on its safety in this population remain limited. This study assessed the safety and tolerability of hepatitis E vaccination in non-pregnant women of childbearing age. Methodology: This prospective, multicenter observational study was conducted at Jinnah Postgraduate Medical Centre and Atiya General Hospital, Karachi, Pakistan, from September 2023 to September 2025. Using non-probability convenience sampling, 375 non-pregnant women aged 16–43 years, stratified into 16–22 and 23–43-year subgroups, received at least one vaccine dose and were followed for 21 days. Data were collected by structured questionnaire and analyzed with descriptive statistics and the Chi-square test, with p ≤ 0.05 considered significant. Results: Among the 375 non-pregnant women (mean age 24.47 ± 5.44 years), 72 (19.2%) were married and 303 (80.8%) unmarried; occupations included students (39.5%), housewives (24.8%), caretakers (14.7%), teachers (6.9%), office workers (5.6%), laborers (5.3%), and doctors (3.2%), and 369 (98.4%) resided in Sindh. Adverse effects were mild, transient, and most frequent after the first dose fever (3.7%), flu-like symptoms (4.8%), headache (1.9%), and cold sores (0.3%) all declining on subsequent follow-ups, with no serious adverse events and similar tolerability across age groups. Conclusion: Hepatitis E vaccination is safe, well-tolerated, and acceptable in non-pregnant women of reproductive age in endemic settings, supporting its inclusion in public health programs to reduce hepatitis E-related morbidity and mortality. Further studies should assess long-term protection and safety in pregnancy.
- 19 September 2026
- Published by Springer Nature in Egyptian Liver Journal
- Vol. 16  (1) , 66
Open AccessHepatitis E vaccination in women of childbearing age: safety and tolerability outcomes
Background and objective: Hepatitis E virus is a major cause of acute viral hepatitis and is endemic in Pakistan, where it contributes substantially to morbidity and mortality among women of childbearing age. The Hecolin vaccine is a potentially useful preventive measure, but data on its safety in this population remain limited. This study assessed the safety and tolerability of hepatitis E vaccination in non-pregnant women of childbearing age. Methodology: This prospective, multicenter observational study was conducted at Jinnah Postgraduate Medical Centre and Atiya General Hospital, Karachi, Pakistan, from September 2023 to September 2025. Using non-probability convenience sampling, 375 non-pregnant women aged 16–43 years, stratified into 16–22 and 23–43-year subgroups, received at least one vaccine dose and were followed for 21 days. Data were collected by structured questionnaire and analyzed with descriptive statistics and the Chi-square test, with p ≤ 0.05 considered significant. Results: Among the 375 non-pregnant women (mean age 24.47 ± 5.44 years), 72 (19.2%) were married and 303 (80.8%) unmarried; occupations included students (39.5%), housewives (24.8%), caretakers (14.7%), teachers (6.9%), office workers (5.6%), laborers (5.3%), and doctors (3.2%), and 369 (98.4%) resided in Sindh. Adverse effects were mild, transient, and most frequent after the first dose fever (3.7%), flu-like symptoms (4.8%), headache (1.9%), and cold sores (0.3%) all declining on subsequent follow-ups, with no serious adverse events and similar tolerability across age groups. Conclusion: Hepatitis E vaccination is safe, well-tolerated, and acceptable in non-pregnant women of reproductive age in endemic settings, supporting its inclusion in public health programs to reduce hepatitis E-related morbidity and mortality. Further studies should assess long-term protection and safety in pregnancy.
- Open Access
- 9 September 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Critical Care Medicine
- Vol. 14  (3) , 105428
Acute liver failure etiology, clinical manifestation and outcomes in adults: Experience of tertiary care hospital in Karachi
BACKGROUND Many causal factors influence acute liver failure (ALF), including the primary underlying cause, age, and socioeconomic conditions. ALF outcomes depend on etiology, coagulopathy, bilirubin, age, and understanding of hepatic encephalopathy (HE), and help us predict coma and death. AIM To evaluate the association between etiologies, clinical manifestations, and outcomes of adults admitted with ALF. METHODS This institution-based, prospective cross-sectional study was conducted in the Department of Gastroenterology and Hepatology at Jinnah Postgraduate Medical Center, Karachi, from July 2019 to December 2022. A total of 102 patients diagnosed with ALF were included using consecutive sampling and data were collected from patients who visited Jinnah Postgraduate Medical Center, Karachi, the gastroenterology and hepatology department, entered into Microsoft Excel, and analyzed using Statistical Package for the Social Sciences version 26.0. Diagnosis was based on King’s College criteria: Age, encephalopathy grade, bilirubin, prothrombin time, international normalized ratio, creatinine, and etiology. We assessed the association between socioeconomic status and various outcomes using chi-square tests with a level of significance was less than 0.05. RESULTS Mean age of the ALF cohort was 27.37 ± 6.60 years. Of the 102 patients, 71 (69.6%) were female, including 55 (77.5%) pregnant women with a mean gestational age of 34.56 ± 3.80 weeks. Regarding HE severity, 45 (44.1%) had grade III, and 13 (12.7%) had grade II. Among the patients admitted to the intensive care unit, 51 (72.9%) did not survive, while 14 (43.8%) recovered. CONCLUSION This study observed a high mortality rate among ALF patients in a tertiary care hospital. Hepatitis E virus infection, HE severity, and sepsis were significantly associated with higher mortality.
- 9 September 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Critical Care Medicine
- Vol. 14  (3) , 105428
Open AccessAcute liver failure etiology, clinical manifestation and outcomes in adults: Experience of tertiary care hospital in Karachi
BACKGROUND Many causal factors influence acute liver failure (ALF), including the primary underlying cause, age, and socioeconomic conditions. ALF outcomes depend on etiology, coagulopathy, bilirubin, age, and understanding of hepatic encephalopathy (HE), and help us predict coma and death. AIM To evaluate the association between etiologies, clinical manifestations, and outcomes of adults admitted with ALF. METHODS This institution-based, prospective cross-sectional study was conducted in the Department of Gastroenterology and Hepatology at Jinnah Postgraduate Medical Center, Karachi, from July 2019 to December 2022. A total of 102 patients diagnosed with ALF were included using consecutive sampling and data were collected from patients who visited Jinnah Postgraduate Medical Center, Karachi, the gastroenterology and hepatology department, entered into Microsoft Excel, and analyzed using Statistical Package for the Social Sciences version 26.0. Diagnosis was based on King’s College criteria: Age, encephalopathy grade, bilirubin, prothrombin time, international normalized ratio, creatinine, and etiology. We assessed the association between socioeconomic status and various outcomes using chi-square tests with a level of significance was less than 0.05. RESULTS Mean age of the ALF cohort was 27.37 ± 6.60 years. Of the 102 patients, 71 (69.6%) were female, including 55 (77.5%) pregnant women with a mean gestational age of 34.56 ± 3.80 weeks. Regarding HE severity, 45 (44.1%) had grade III, and 13 (12.7%) had grade II. Among the patients admitted to the intensive care unit, 51 (72.9%) did not survive, while 14 (43.8%) recovered. CONCLUSION This study observed a high mortality rate among ALF patients in a tertiary care hospital. Hepatitis E virus infection, HE severity, and sepsis were significantly associated with higher mortality.
- Open Access
- 1 January 2025
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 15  (2) , 200-203
A Rare Lymphoproliferative Disorder in a Teenager with Spontaneous Resolution on Positron Emission Tomography Scan
Butt N, Mohiuddin G, Idris O, et al. A Rare Lymphoproliferative Disorder in a Teenager with Spontaneous Resolution on Positron Emission Tomography Scan. Euroasian J Hepato-Gastroenterol 2025;15(2):200–203.
- 1 January 2025
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 15  (2) , 200-203
Open AccessA Rare Lymphoproliferative Disorder in a Teenager with Spontaneous Resolution on Positron Emission Tomography Scan
Butt N, Mohiuddin G, Idris O, et al. A Rare Lymphoproliferative Disorder in a Teenager with Spontaneous Resolution on Positron Emission Tomography Scan. Euroasian J Hepato-Gastroenterol 2025;15(2):200–203.
- Open Access
- 12 June 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14  (1) , 16-19
Hepatitis B Risk Factors are Frequently Present in Children at Jinnah Postgraduate Medical Centre in Karachi
Infection with the hepatitis B virus (HBV) poses a serious threat to global public health. More than 300 million instances of chronic hepatitis are brought on by it, which is the primary cause of liver disease. This study was conducted to determine the risk factors of HBV in children at Jinnah Postgraduate Medical Centre, Karachi, Sindh, Pakistan. This cross-sectional study was conducted at the Department of Gastroenterology, Jinnah Postgraduate Medical Centre, Karachi, Sindh, Pakistan from January 2019 to April 2022. A total of 134 children aged below 16 years with HBV were recruited in this study. Demographic information was recorded. Screening for HBV was done in all patients. Investigations including liver biochemistry, hepatitis B surface antigen (HBsAg), and HBV DNA polymerase chain reaction (PCR) were conducted in the hospital along with a complete blood count and ultrasound whole abdomen. All information was collected on a predesigned proforma and evaluated using statistical package for the social sciences (SPSS), version 25.0, software. The mean age of patients was 11.02 ± 2.19 years. There were 57.46% males. The frequent risk factor was vertical transmission in 47% of children followed by blood transfusion in 23.9% of children, horizontal transmission in 13.4% of children, and prior history of surgical or dental intervention in 17.2% of children. In this study, vertical transmission was the most common route of transmission of HBV. Additionally, 11% of family members were HBV positive. None had concomitant hepatitis C virus (HCV) and HDV infection. All pregnant females should be screened. Children on chronic blood transfusion therapy should be screened annually. Additionally, birth-dose HBV vaccination should be implemented as a key step in HBV prevention among Pakistani children. Butt N, Kamani L, Khemani H. Hepatitis B Risk Factors are Frequently Present in Children at Jinnah Postgraduate Medical Centre in Karachi. Euroasian J Hepato-Gastroenterol 2024;14(1):16–19.
- 12 June 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14  (1) , 16-19
Open AccessHepatitis B Risk Factors are Frequently Present in Children at Jinnah Postgraduate Medical Centre in Karachi
Infection with the hepatitis B virus (HBV) poses a serious threat to global public health. More than 300 million instances of chronic hepatitis are brought on by it, which is the primary cause of liver disease. This study was conducted to determine the risk factors of HBV in children at Jinnah Postgraduate Medical Centre, Karachi, Sindh, Pakistan. This cross-sectional study was conducted at the Department of Gastroenterology, Jinnah Postgraduate Medical Centre, Karachi, Sindh, Pakistan from January 2019 to April 2022. A total of 134 children aged below 16 years with HBV were recruited in this study. Demographic information was recorded. Screening for HBV was done in all patients. Investigations including liver biochemistry, hepatitis B surface antigen (HBsAg), and HBV DNA polymerase chain reaction (PCR) were conducted in the hospital along with a complete blood count and ultrasound whole abdomen. All information was collected on a predesigned proforma and evaluated using statistical package for the social sciences (SPSS), version 25.0, software. The mean age of patients was 11.02 ± 2.19 years. There were 57.46% males. The frequent risk factor was vertical transmission in 47% of children followed by blood transfusion in 23.9% of children, horizontal transmission in 13.4% of children, and prior history of surgical or dental intervention in 17.2% of children. In this study, vertical transmission was the most common route of transmission of HBV. Additionally, 11% of family members were HBV positive. None had concomitant hepatitis C virus (HCV) and HDV infection. All pregnant females should be screened. Children on chronic blood transfusion therapy should be screened annually. Additionally, birth-dose HBV vaccination should be implemented as a key step in HBV prevention among Pakistani children. Butt N, Kamani L, Khemani H. Hepatitis B Risk Factors are Frequently Present in Children at Jinnah Postgraduate Medical Centre in Karachi. Euroasian J Hepato-Gastroenterol 2024;14(1):16–19.
- Open Access
- 12 June 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14  (1) , 51-55
Efficacy of Pegylated Interferon-alpha-2a in Chronic Hepatitis Delta: Experience from a Tertiary Care Hospital in Karachi
Chronic hepatitis D (CHD) along with chronic hepatitis B (CHB) is an important cause of morbidity and mortality in patients with cirrhosis. It is a potentially curable infection that has long awaited a good treatment option. To ascertain the efficacy of pegylated interferon (PEG-IFN)-alpha-2a in patients suffering from CHD. A tertiary care hospital experience from Pakistan. The study included 207 CHD polymerase chain reaction (PCR)-positive patients treated with PEG-IFN-alpha-2a between July 2020 and October 2022. Virological response rate (PCR negative) at weeks 24 and 48 was the primary endpoint. Secondary outcomes included partial response (>2 log reduction in PCR) and treatment failure rate (<2 log reduction in PCR). A total of 187 patients started PEG-IFN therapy, and 148 patients completed the assigned 48 weeks of therapy. Patients' mean age was 25.7 years with 65% being males. The virological response rate was 40.5% at week 24 and 32.4% at week 48. The partial response rate was 24% at both weeks 24 and 48. The treatment failure rate was 36% at week 24 and 44% at week 48. Hemoglobin, white blood cell (WBC) count, and total bilirubin were found to be predictive of treatment response. Side effects led to treatment discontinuation among eighteen patients and one patient died due to hepatic failure. Therapy with PEG-IFN-alpha-2a shows suboptimal outcomes in patients with CHD. There is a strong need for more effective alternate therapies for CHD patients. Butt N, Usmani MT, Hussain R, et al. Efficacy of Pegylated Interferon-alpha-2a in Chronic Hepatitis Delta: Experience from a Tertiary Care Hospital in Karachi. Euroasian J Hepato-Gastroenterol 2024;14(1):51–55.
- 12 June 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14  (1) , 51-55
Open AccessEfficacy of Pegylated Interferon-alpha-2a in Chronic Hepatitis Delta: Experience from a Tertiary Care Hospital in Karachi
Chronic hepatitis D (CHD) along with chronic hepatitis B (CHB) is an important cause of morbidity and mortality in patients with cirrhosis. It is a potentially curable infection that has long awaited a good treatment option. To ascertain the efficacy of pegylated interferon (PEG-IFN)-alpha-2a in patients suffering from CHD. A tertiary care hospital experience from Pakistan. The study included 207 CHD polymerase chain reaction (PCR)-positive patients treated with PEG-IFN-alpha-2a between July 2020 and October 2022. Virological response rate (PCR negative) at weeks 24 and 48 was the primary endpoint. Secondary outcomes included partial response (>2 log reduction in PCR) and treatment failure rate (<2 log reduction in PCR). A total of 187 patients started PEG-IFN therapy, and 148 patients completed the assigned 48 weeks of therapy. Patients' mean age was 25.7 years with 65% being males. The virological response rate was 40.5% at week 24 and 32.4% at week 48. The partial response rate was 24% at both weeks 24 and 48. The treatment failure rate was 36% at week 24 and 44% at week 48. Hemoglobin, white blood cell (WBC) count, and total bilirubin were found to be predictive of treatment response. Side effects led to treatment discontinuation among eighteen patients and one patient died due to hepatic failure. Therapy with PEG-IFN-alpha-2a shows suboptimal outcomes in patients with CHD. There is a strong need for more effective alternate therapies for CHD patients. Butt N, Usmani MT, Hussain R, et al. Efficacy of Pegylated Interferon-alpha-2a in Chronic Hepatitis Delta: Experience from a Tertiary Care Hospital in Karachi. Euroasian J Hepato-Gastroenterol 2024;14(1):51–55.
- Open Access
- 12 June 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14  (1) , 24-29
Clinical Spectrum of Celiac Disease among Adult Population: Experience from Largest Tertiary Care Hospital in Karachi, Pakistan
Celiac disease (CD) is a systemic autoimmune enteropathy triggered by dietary gluten in genetically susceptible individuals. Celiac disease affects 0.6–1.0% of the population worldwide. The prevalence of CD in Pakistan is yet unknown due to under diagnosis and lack of awareness. To determine a vast variety of presenting features in subtypes of CD to overcome the burden of disease. This was a prospective, comparative, cross-sectional study conducted at Gastroenterology department of Jinnah Postgraduate Medical Center, Karachi from December 2022 till June 2023. This study included all adult patients ≥18 years diagnosed with CD on the basis of clinical presentation, positive IgA and IgG anti-transglutaminase antibodies (value >12 IU/mL detected by ELISA followed by small intestinal biopsy classified as per Marsh criteria. The data obtained were analyzed on the statistical software SPSS version 23. Descriptive statistics were obtained by frequencies and percentages. About 142 patients were enrolled in the study, 103 (91.5%) had classical CD (CCD) whereas 36 (25%) had non-classical (NCCD). About 89 (62.7%) were females and 53 (37.3%) were males. The mean age was found to be 23 ± 6 years. Nutritional deficiencies including anemia, B12, folate, osteopenia and low body mass index (BMI) <18 was found more in CCD group as compared with NCCD group with significant p-values. Titers of anti-TTG between CCD and NCCD were not statistically significant. Hypothyroidism and PCOS were the most common associated conditions observed in adult CD patients. In conclusion, CD in adults and has diverse presentations. Adults with unexplained extra-intestinal symptoms like anemia and bone pain should be investigated for CD. Butt N, Shahid B, Butt S, et al. Clinical Spectrum of Celiac Disease among Adult Population: Experience from Largest Tertiary Care Hospital in Karachi, Pakistan. Euroasian J Hepato-Gastroenterol 2024;14(1):24–29.
- 12 June 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14  (1) , 24-29
Open AccessClinical Spectrum of Celiac Disease among Adult Population: Experience from Largest Tertiary Care Hospital in Karachi, Pakistan
Celiac disease (CD) is a systemic autoimmune enteropathy triggered by dietary gluten in genetically susceptible individuals. Celiac disease affects 0.6–1.0% of the population worldwide. The prevalence of CD in Pakistan is yet unknown due to under diagnosis and lack of awareness. To determine a vast variety of presenting features in subtypes of CD to overcome the burden of disease. This was a prospective, comparative, cross-sectional study conducted at Gastroenterology department of Jinnah Postgraduate Medical Center, Karachi from December 2022 till June 2023. This study included all adult patients ≥18 years diagnosed with CD on the basis of clinical presentation, positive IgA and IgG anti-transglutaminase antibodies (value >12 IU/mL detected by ELISA followed by small intestinal biopsy classified as per Marsh criteria. The data obtained were analyzed on the statistical software SPSS version 23. Descriptive statistics were obtained by frequencies and percentages. About 142 patients were enrolled in the study, 103 (91.5%) had classical CD (CCD) whereas 36 (25%) had non-classical (NCCD). About 89 (62.7%) were females and 53 (37.3%) were males. The mean age was found to be 23 ± 6 years. Nutritional deficiencies including anemia, B12, folate, osteopenia and low body mass index (BMI) <18 was found more in CCD group as compared with NCCD group with significant p-values. Titers of anti-TTG between CCD and NCCD were not statistically significant. Hypothyroidism and PCOS were the most common associated conditions observed in adult CD patients. In conclusion, CD in adults and has diverse presentations. Adults with unexplained extra-intestinal symptoms like anemia and bone pain should be investigated for CD. Butt N, Shahid B, Butt S, et al. Clinical Spectrum of Celiac Disease among Adult Population: Experience from Largest Tertiary Care Hospital in Karachi, Pakistan. Euroasian J Hepato-Gastroenterol 2024;14(1):24–29.
- Open Access
- 16 December 2023
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 40  (3) , 284-290
Outcomes of liver diseases in pregnant females: A study from a tertiary care medical center in Pakistan
Objective: To determine the etiologies and outcomes of liver disease in pregnancy in a developing country. Method: A total of 336 consecutive pregnant women with liver disease were included in this prospective cohort study conducted at the Department of Gastroenterology, Jinnah Postgraduate Medical Center, Karachi from August 2019 to August 2021. Patients’ baseline demographic, clinical, and laboratory data and outcomes were collected on a pre-designed questionnaire. Results: Among all the pregnant females, the most common liver disease was acute hepatitis E virus (HEV) infection (37.2%), followed by preeclampsia (PEC)/eclampsia (EC), hemolysis, elevated liver enzymes & low platelets (HELLP) syndrome, and hyperemesis gravidarum (HG). The most common maternal complications were fulminant hepatic failure (FHF) in 14.9% and placental abruption in 11.0%. Fetal complications included intrauterine death (IUD) in 20.8% and preterm birth in 8.6%. The maternal and neonatal mortality rates were 11.6% and 39.6%, respectively. Among the predictors, low maternal weight, low body mass index (BMI), and low hemoglobin (Hb) were associated with increased maternal mortality. Low fetal weight, height, maternal systolic blood pressure (SBP), and low maternal Hb were independent predictors of fetal mortality. Conclusion: In our cohort of pregnant females in a tertiary care medical center, acute HEV was the most common liver disease, followed by PEC/EC, HELLP, and HG. Maternal and fetal deaths were alarming in this group of patients and demanded careful management. doi: https://doi.org/10.12669/pjms.40.3.7670 How to cite this: Butt N, Ali S, Yasmeen H, Mumtaz K. Outcomes of liver diseases in pregnant females: A study from a tertiary care medical center in Pakistan. Pak J Med Sci. 2024;40(3):284-290. doi: https://doi.org/10.12669/pjms.40.3.7670 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- 16 December 2023
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 40  (3) , 284-290
Open AccessOutcomes of liver diseases in pregnant females: A study from a tertiary care medical center in Pakistan
Objective: To determine the etiologies and outcomes of liver disease in pregnancy in a developing country. Method: A total of 336 consecutive pregnant women with liver disease were included in this prospective cohort study conducted at the Department of Gastroenterology, Jinnah Postgraduate Medical Center, Karachi from August 2019 to August 2021. Patients’ baseline demographic, clinical, and laboratory data and outcomes were collected on a pre-designed questionnaire. Results: Among all the pregnant females, the most common liver disease was acute hepatitis E virus (HEV) infection (37.2%), followed by preeclampsia (PEC)/eclampsia (EC), hemolysis, elevated liver enzymes & low platelets (HELLP) syndrome, and hyperemesis gravidarum (HG). The most common maternal complications were fulminant hepatic failure (FHF) in 14.9% and placental abruption in 11.0%. Fetal complications included intrauterine death (IUD) in 20.8% and preterm birth in 8.6%. The maternal and neonatal mortality rates were 11.6% and 39.6%, respectively. Among the predictors, low maternal weight, low body mass index (BMI), and low hemoglobin (Hb) were associated with increased maternal mortality. Low fetal weight, height, maternal systolic blood pressure (SBP), and low maternal Hb were independent predictors of fetal mortality. Conclusion: In our cohort of pregnant females in a tertiary care medical center, acute HEV was the most common liver disease, followed by PEC/EC, HELLP, and HG. Maternal and fetal deaths were alarming in this group of patients and demanded careful management. doi: https://doi.org/10.12669/pjms.40.3.7670 How to cite this: Butt N, Ali S, Yasmeen H, Mumtaz K. Outcomes of liver diseases in pregnant females: A study from a tertiary care medical center in Pakistan. Pak J Med Sci. 2024;40(3):284-290. doi: https://doi.org/10.12669/pjms.40.3.7670 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Open Access
- 25 October 2023
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 40  (1) , 55-59
Epidemiological and clinical characteristics of esophageal carcinoma: An experience from tertiary care hospital of Karachi, Pakistan
Objectives: To describe current trends and characteristics of esophageal cancer (EC) over the past ten years largest tertiary care hospital of Karachi, Pakistan. Methods: This single center retrospective study was conducted at the Department of Gastroenterology and Oncology, Jinnah Postgraduate Medical Center, Karachi, Pakistan, between the period of ten years from 1st January 2010 to 31st December 2019. Patient data including epidemiological characteristics such as age, gender, education, residence, occupation, addictions, comorbidities, symptoms, location of EC, laboratory parameters and histopathological type were recorded. All patients with missing histological and radiological findings were excluded. Results: The mean age of all patients was 49.26±14.24 years and among them majority were females 566 (56.1%). Almost, 834 (82.7%) patients had SQC and 175 (17.3%) presented with ADS. Most common presenting symptom was dysphagia in both groups 327 (32.4%) followed by vomiting (22.8%) and weight loss 196 (19.4%). The Esophagogastroduodenoscopy (EGD) findings showed the distal esophagus involvement in most of the patients (36.3%) in both groups. CT scan findings showed that the lower region was the most involved region in 367 (36.4%) patients, followed by middle and upper in 227 (22.5%) and 156 (15.5%) patients respectively. The thickening of mass on CT- scan was circumferential in most of the patients (42.7%) in both groups. Conclusion: According to our findings, SQC is more prevalent than ADC. Female predominance especially at younger age was most common as compared to past studies. No significant association between a single risk factor has been found in our study however smoking and betel nut chewing were found as known putative risk factors. doi: https://doi.org/10.12669/pjms.40.1.7419 How to cite this: Butt N, Soomro SA, Haider G, Zehra A. Epidemiological and clinical characteristics of esophageal carcinoma: An experience from tertiary care hospital of Karachi, Pakistan. Pak J Med Sci. 2024;40(1):55-59. doi: https://doi.org/10.12669/pjms.40.1.7419 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- 25 October 2023
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 40  (1) , 55-59
Open AccessEpidemiological and clinical characteristics of esophageal carcinoma: An experience from tertiary care hospital of Karachi, Pakistan
Objectives: To describe current trends and characteristics of esophageal cancer (EC) over the past ten years largest tertiary care hospital of Karachi, Pakistan. Methods: This single center retrospective study was conducted at the Department of Gastroenterology and Oncology, Jinnah Postgraduate Medical Center, Karachi, Pakistan, between the period of ten years from 1st January 2010 to 31st December 2019. Patient data including epidemiological characteristics such as age, gender, education, residence, occupation, addictions, comorbidities, symptoms, location of EC, laboratory parameters and histopathological type were recorded. All patients with missing histological and radiological findings were excluded. Results: The mean age of all patients was 49.26±14.24 years and among them majority were females 566 (56.1%). Almost, 834 (82.7%) patients had SQC and 175 (17.3%) presented with ADS. Most common presenting symptom was dysphagia in both groups 327 (32.4%) followed by vomiting (22.8%) and weight loss 196 (19.4%). The Esophagogastroduodenoscopy (EGD) findings showed the distal esophagus involvement in most of the patients (36.3%) in both groups. CT scan findings showed that the lower region was the most involved region in 367 (36.4%) patients, followed by middle and upper in 227 (22.5%) and 156 (15.5%) patients respectively. The thickening of mass on CT- scan was circumferential in most of the patients (42.7%) in both groups. Conclusion: According to our findings, SQC is more prevalent than ADC. Female predominance especially at younger age was most common as compared to past studies. No significant association between a single risk factor has been found in our study however smoking and betel nut chewing were found as known putative risk factors. doi: https://doi.org/10.12669/pjms.40.1.7419 How to cite this: Butt N, Soomro SA, Haider G, Zehra A. Epidemiological and clinical characteristics of esophageal carcinoma: An experience from tertiary care hospital of Karachi, Pakistan. Pak J Med Sci. 2024;40(1):55-59. doi: https://doi.org/10.12669/pjms.40.1.7419 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Open Access
- 29 November 2022
- Published by Springer Nature in Research Square
Outcomes of Liver Diseases in Pregnant Females: A Study from a Large Tertiary Care Medical Center in Pakistan.
Purpose: Liver diseases are uncommon in pregnant females but challenging to manage. The present study aimed to determine the etiologies and outcomes of liver disease in pregnancy in a developing country. Methodology: We included a total of 336 consecutive pregnant women with liver disease seen at the Department of Gastroenterology, Jinnah Postgraduate Medical Center from August 2019 to August 2021. Patients’ baseline demographic, clinical, and laboratory data and outcomes were collected on a pre-designed questionnaire. Results: Among all the pregnant females, the most common liver disease was acute hepatitis E virus (HEV) infection (37.2%), followed by preeclampsia/eclampsia, hemolysis, elevated liver enzymes & low platelets (HELLP) syndrome, and hyperemesis gravidarum (HG). The most common maternal complications were a fulminant hepatic failure (FHF) in 14.9% and placental abruption in 11.0%. Fetal complications included intrauterine death (IUD) in 20.8% and preterm birth in 8.6%. The maternal and neonatal mortality rates were 11.6% and 39.6%, respectively. Among the predictors, low maternal weight, low body mass index (BMI), low hemoglobin (Hb), were associated with the increased maternal mortality. Low fetal weight, height, low maternal systolic blood pressure (SBP), low maternal Hb were the independent predictors of fetal mortality. Conclusion: In our cohort of pregnant females in a tertiary care medical center, acute HEV was the most common liver disease, followed by preeclampsia/eclampsia, HELLP, and HG. Maternal and fetal deaths were alarming in this group of patients and demand careful management.
- 29 November 2022
- Published by Springer Nature in Research Square
Open AccessOutcomes of Liver Diseases in Pregnant Females: A Study from a Large Tertiary Care Medical Center in Pakistan.
Purpose: Liver diseases are uncommon in pregnant females but challenging to manage. The present study aimed to determine the etiologies and outcomes of liver disease in pregnancy in a developing country. Methodology: We included a total of 336 consecutive pregnant women with liver disease seen at the Department of Gastroenterology, Jinnah Postgraduate Medical Center from August 2019 to August 2021. Patients’ baseline demographic, clinical, and laboratory data and outcomes were collected on a pre-designed questionnaire. Results: Among all the pregnant females, the most common liver disease was acute hepatitis E virus (HEV) infection (37.2%), followed by preeclampsia/eclampsia, hemolysis, elevated liver enzymes & low platelets (HELLP) syndrome, and hyperemesis gravidarum (HG). The most common maternal complications were a fulminant hepatic failure (FHF) in 14.9% and placental abruption in 11.0%. Fetal complications included intrauterine death (IUD) in 20.8% and preterm birth in 8.6%. The maternal and neonatal mortality rates were 11.6% and 39.6%, respectively. Among the predictors, low maternal weight, low body mass index (BMI), low hemoglobin (Hb), were associated with the increased maternal mortality. Low fetal weight, height, low maternal systolic blood pressure (SBP), low maternal Hb were the independent predictors of fetal mortality. Conclusion: In our cohort of pregnant females in a tertiary care medical center, acute HEV was the most common liver disease, followed by preeclampsia/eclampsia, HELLP, and HG. Maternal and fetal deaths were alarming in this group of patients and demand careful management.